Search

Your search keyword '"Ian Chopra"' showing total 129 results

Search Constraints

Start Over You searched for: Author "Ian Chopra" Remove constraint Author: "Ian Chopra" Topic biology Remove constraint Topic: biology
129 results on '"Ian Chopra"'

Search Results

1. The 2012 Garrod Lecture: Discovery of antibacterial drugs in the 21st century

2. The silver cation (Ag+): antistaphylococcal activity, mode of action and resistance studies

3. Structure-Based Ligand Design of Novel Bacterial RNA Polymerase Inhibitors

4. Characterization of Global Patterns and the Genetics of Fusidic Acid Resistance

5. Activity of and Development of Resistance to Corallopyronin A, an Inhibitor of RNA Polymerase

6. Small molecule inhibitors of peptidoglycan synthesis targeting the lipid II precursor

7. Furanyl-Rhodanines Are Unattractive Drug Candidates for Development as Inhibitors of Bacterial RNA Polymerase

8. Functional and Biochemical Analysis of theChlamydia trachomatisLigase MurE

9. XF-70 and XF-73, novel antibacterial agents active against slow-growing and non-dividing cultures of Staphylococcus aureus including biofilms

10. Analysis of mutational resistance to trimethoprim in Staphylococcus aureus by genetic and structural modelling techniques

11. The nature ofStaphylococcus aureusMurA and MurZ and approaches for detection of peptidoglycan biosynthesis inhibitors

12. Transcriptional Signature following Inhibition of Early-Stage Cell Wall Biosynthesis in Staphylococcus aureus

13. Consequences of daptomycin-mediated membrane damage in Staphylococcus aureus

14. Delayed Development of Linezolid Resistance in Staphylococcus aureus following Exposure to Low Levels of Antimicrobial Agents

15. Linezolid and Tiamulin Cross-Resistance in Staphylococcus aureus Mediated by Point Mutations in the Peptidyl Transferase Center

16. High prevalence of resistance to fusidic acid in clinical isolates of Staphylococcus epidermidis

17. Treatment of health-care-associated infections caused by Gram-negative bacteria: a consensus statement

18. Emergence and maintenance of resistance to fluoroquinolones and coumarins in Staphylococcus aureus: predictions from in vitro studies

19. Characterization of the Epidemic European Fusidic Acid-Resistant Impetigo Clone of Staphylococcus aureus

20. Mechanisms of the post-antibiotic effects induced by rifampicin and gentamicin in Escherichia coli

21. Molecular Genetic and Structural Modeling Studies of Staphylococcus aureus RNA Polymerase and the Fitness of Rifampin Resistance Genotypes in Relation to Clinical Prevalence

22. Molecular basis offusB-mediated resistance to fusidic acid inStaphylococcus aureus

23. Antistaphylococcal activity of the novel cephalosporin CB-181963 (CAB-175)

24. A Fusidic Acid-Resistant Epidemic Strain of Staphylococcus aureus Carries the fusB Determinant, whereas fusA Mutations Are Prevalent in Other Resistant Isolates

25. Escherichia coli Mutators Present an Enhanced Risk for Emergence of Antibiotic Resistance during Urinary Tract Infections

26. The Target of Daptomycin Is Absent from Escherichia coli and Other Gram-Negative Pathogens

27. Antibiotic resistance in Staphylococcus aureus: concerns, causes and cures

28. Macrocyclic inhibitors of the bacterial cell wall biosynthesis enzyme mur D

29. Biological Properties of Novel Antistaphylococcal Quinoline-Indole Agents

30. Response of Escherichia coli hypermutators to selection pressure with antimicrobial agents from different classes

31. New developments in tetracycline antibiotics: glycylcyclines and tetracycline efflux pump inhibitors

32. Further Characterization of Bacillus subtilis Antibiotic Biosensors and Their Use for Antibacterial Mode-of-Action Studies

33. Glycylcyclines: third-generation tetracycline antibiotics

34. Tetracycline Antibiotics: Mode of Action, Applications, Molecular Biology, and Epidemiology of Bacterial Resistance

35. Antimicrobial Properties and Mode of Action of the Pyrrothine Holomycin

36. RNA Polymerase Inhibitors with Activity against Rifampin-Resistant Mutants of Staphylococcus aureus

37. Expression of the Staphylococcus aureus UDP- N -Acetylmuramoyl- <scp>l</scp> -Alanyl- <scp>d</scp> -Glutamate: <scp>l</scp> -Lysine Ligase in Escherichia coli and Effects on Peptidoglycan Biosynthesis and Cell Growth

38. Antibiotics, peptidoglycan synthesis and genomics: the chlamydial anomaly revisited

39. Protein synthesis as a target for antibacterial drugs: current status and future opportunities

40. Over-expression of target genes as a mechanism of antibiotic resistance in bacteria

41. Evolution of extended-spectrum -lactamases in a MutS-deficient Pseudomonas aeruginosa hypermutator

42. In vivo transfer of high-level mupirocin resistance from Staphylococcus epidermidis to methicillin-resistant Staphylococcus aureus associated with failure of mupirocin prophylaxis

43. Population diversification in Staphylococcus aureus biofilms may promote dissemination and persistence

44. Antibacterial activity and mode of action of tert-butylhydroquinone (TBHQ) and its oxidation product, tert-butylbenzoquinone (TBBQ)

46. Comparison of assays for detection of agents causing membrane damage in Staphylococcus aureus

47. Staphylococcus aureus biofilms promote horizontal transfer of antibiotic resistance

48. SB 205952, a novel semisynthetic monic acid analog with at least two modes of action

49. Increased Mutability of Staphylococci in Biofilms as a Consequence of Oxidative Stress

50. 6-Arylpyrido[2,3-d]pyrimidines as novel ATP-competitive inhibitors of bacterial D-alanine:D-alanine ligase

Catalog

Books, media, physical & digital resources